Traub Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$270K Sell
640
-45
-7% -$17.9K 0.24% 99
2026
Q2
$248K Hold
685
– – 0.22% 110
2026
Q1
$241K Sell
685
-15
-2% -$5.35K 0.24% 104
2025
Q4
$229K Sell
700
-10
-1% -$3.17K 0.22% 112
2025
Q3
$200K Buy
710
+203
+40% +$58.9K 0.2% 123
2025
Q2
$141K Buy
+507
New +$144K 0.13% 141

Other funds holding AMGN

Traub Capital Management's AMGN Position: Q3 2026 in Review

Traub Capital Management reduced its Amgen (AMGN) stake by 6.6% in Q3 2026, selling an estimated $17.9K and leaving 640 shares worth $270K. The position accounts for 0.24% of the portfolio, ranked #99.

Traub Capital Management first reported a position in AMGN in Q2 2025 and has held it in 6 quarters since. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Traub Capital Management held 640 shares of Amgen worth $270K as of Q3 2026.
  • Traub Capital Management sold 45 Amgen shares in Q3 2026, an estimated $17.9K.
  • Amgen made up 0.24% of Traub Capital Management's portfolio in Q3 2026, its #99 holding.
  • Traub Capital Management first reported a position in Amgen in Q2 2025 and has held it in 6 quarters since.
  • 2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Traub Capital Management's 13F filing for Q3 2026, filed 9 Nov 2026.